Eisai, Biogen announce TGA of Australia declined approval of lecanemab
Eisai (ESAIY) and Biogen (BIIB) announced that the Therapeutic Goods Administration, TGA, of Australia has confirmed the initial decision to ...
Armed robbery in Revesby3d
TGA Confirms Decision To Not Register Lecanemab
In October 2024, the TGA made the decision not to register lecanemab (LEQEMBI) on the Australian Register of Therapeutic Goods (ARTG) for the ...
Gaming Legends on MSN3d
Kingdom Hearts 4: 2025 Reveal Almost Here at TGA
"TheGamersJoint brings you the latest gaming news, reviews, and in-depth discussions about all your favorite video games. From game theories and analysis to exciting updates and reviews, we cover ...
Labor backs local IV fluid maker to hedge against supply shocks
Labor said Baxter Healthcare, the only local manufacturer of IV fluids, will match the government’s investment, which will ...
GamesIndustry3d
The Game Assembly expands to UK in partnership with City of Liverpool College
Swedish game development school The Game Assembly has announced its expansion to the UK, offering its education model ...
Daily4h
Avecho, Sandoz ink pact to commercialise CBD for insomnia in Australia
Melbourne: Avecho Biotechnology Limited has announced it has signed an exclusive ten-year development and licensing agreement ...
The Australian Financial Review16d
TGA approves weight-loss drug to treat heart disease
AP The TGA approval – made in December and confirmed by Novo Nordisk on Monday – was welcomed by pharmaceutical giants that hope regulatory approval for other applications beyond weight loss ...
Specialised Therapeutics announces TGA approval of YORVIPATH
Specialised Therapeutics welcomes the registration of YORVIPATH by the Therapeutic Goods Administration, “for the treatment of chronic ...
Eisai Receives Regulatory Review Outcome For Lecanemab As A Treatment For Early Alzheimer's Disease In Australia
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia TOKY ...